Cure My Disease

Don't miss your cure!

 Log in / Sign up

The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?

NCT ID NCT07720765

Recruiting now Knowledge-focused Sponsor: IRCCS San Raffaele Source: ClinicalTrials.gov ↗

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This study is testing whether a non-invasive eye scan called optical coherence tomography (OCT) can help track neurological diseases like multiple sclerosis, Alzheimer's, Parkinson's, and migraine. Over two years, researchers will measure the thickness of retinal layers in 840 patients and 210 healthy volunteers, comparing changes to standard clinical tests and brain imaging. The goal is to see if OCT can serve as a quick, painless way to monitor nerve damage in the brain over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Optical coherence tomography (OCT) — a non-invasive eye scan that measures retinal layer thickness
What this could lead to
If successful, this could establish OCT as a simple, routine tool to monitor nerve damage in common brain diseases, potentially catching changes earlier than current methods.
What could go wrong
This is an observational study, not a treatment trial. It will measure correlations, not prove that OCT improves patient outcomes. Results may not change practice if the scans don't reliably predict disease progression.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease headache disorder migraine disorder multiple sclerosis Nerve Degeneration Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE HEADACHE DISORDERS MIGRAINE MULTIPLE SCLEROSIS PARKINSON DISEASE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • IRCCS Ospedale San Raffaele - Neurology and Neurophysiology Unit

    RECRUITING

    Milan, Milano, 20132, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.